Go to the content

Affidea: webinar- State of the art MR-imaging in dementia: How AI and innovation can support differential diagnosis

May 26, 2021


In this webinar we discuss the role of MR imaging in dementia and how emerging AI technologies can support differential diagnosis and provide invaluable information for disease management.

With new disease modifying treatments on the horizon this could bring significant improvements in quality of life for patients and their families alike.


18:00 – 17:05

Dr. Alessandro Roncacci, Senior Vice President Affidea - Introduction

18:05 – 18:30

Dr. Maria Politi - "The Role of Neuroimaging in Dementia"

Key points:

  • A systematic approach for MRI in Dementia
  • Typical imaging findings in the most common dementia syndromes
  • An overview of neurodegenerative disorders which may be associated with dementia.

18:30 – 18:55

Dr. Melissa Verheijen - "The use of MRI quantification in the differential diagnosis of dementia"

Key points:

  • MRI in dementia & Alzheimer’s Disease
    • Normal ageing vs pathological ageing
  • How can we extract more information from MRIs to reduce the time to diagnosis?
  • Automated quantitative analysis to detect & diagnose
  • The future: MRI to monitor Disease Modifying Therapies for Alzheimer’s Disease

18:55 – 19:00


Politi Maria Affidea

Dr Maria Politi

Dr Maria Politi is Affidea’s Neuroimaging Subspecialty Expert. She has a wealth of experience as a co-investigator in clinical trials in the field of stroke medicine with over 50 publications, more than 700 citations and numerous lectures. She also participated in writing the Clinical recommendations for Mechanical Thrombectomy in Patients with Acute Stroke for the Hellenic Stroke Organisation.

Dr Politi graduated from the Medical School of Thessaly University (2001) and trained as a Radiologist and Neuroradiologist at University Hospital of Saarland, Germany (2010). She was trained on Neuroimaging as a clinical Research Fellow at the German Cancer Center at University of Heidelberg, Germany (2005-2006). She received her PhD in fMRI with the thesis “Brain plasticity in patients with complete achromatopsia” from the University of Saarland (2014), degree “summa cum laute”, and achieved subspecialty status as a Diagnostic and Interventional radiologist in Germany.

From 2012 until 2018, Maria served as a Consultant in the department of Diagnostic and Interventional Neuroradiology in Bremen, Germany. In 2018 she took up a role at the Henry Dunant Hospital in Athens for endovascular treatments and was appointed Head of Neuroimaging in Affidea Greece in 2019.

Verheijen Melissa icometrix

Dr. Melissa Verheijen

Dr. Melissa Verheijen attended University College London from 2015-2019, where she received her PhD in Immunology, and developed a desire to improve patient healthcare. She subsequently went on to become a clinical expert for icometrix, a company that leverages artificial intelligence for the volumetric quantification of brain structures on MRI in patients with neurological conditions. Focusing mainly on dementia and multiple sclerosis, she guides clinicians on how to make more evidence-based decisions and how icometrix can assist in this.

Event Information

Event Date26.05.2021 6:00 pm CET
Event End Date26.05.2021 7:00 pm CET
Registration Start Date10.05.2021 11:00 pm
Individual PriceFree




Related Events

How can we help?

The Leuven MindGate team is at your disposal for any questions about the Leuven Innovation Region. Do you want to invest, work or study in the region? We can help you find your way.

We also facilitate collaboration and innovation between companies, knowledge institutes and government within the Leuven Innovation Region, and we are happy to guide any of these stakeholders towards innovation.